Survey on Xiaoke pill treating diabetes mellitus in small cities‘ Chinese medicine hospital for post-marketing surveillance Post-marketing re-evaluation of Kudiezi injection study on early treatment in patients with ischemic stroke Post-marketed re-evaluation of fleabane injection and Dengzhan Shengmai capsule study on treatment in patients with ischemic stroke Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital Thought on several problems of post-marketing herbs clinical evaluation in special populations Basic requirements on post-marketing clinical re-evaluation of Chinese medicine and phase Ⅳ clinical trials